Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesenchymal Stem Cells for Severe Acute Kidney Injury
NCT04194671Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Dec 2021
- Primary completion
- Oct 2022
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in acute kidney injury (AKI), sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT04194671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04194671.